Metformin inhibits 7,12-dimethylbenz[a]anthracene-induced breast carcinogenesis and adduct formation in human breast cells by inhibiting the cytochrome P4501A1/aryl hydrocarbon receptor signaling pathway

Published 2015 View Full Article

Authors

Keywords

Breast cancer, MCF10A cells, Metformin, Cytochrome P4501A1, DNA damage, AhR

Journal

TOXICOLOGY AND APPLIED PHARMACOLOGY

Volume 284, Issue 2, Pages 217-226

Publisher

Elsevier BV

Online

2015-02-17

DOI

10.1016/j.taap.2015.02.007

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started